HSBC Holdings’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142K Buy
+34,288
New +$166K ﹤0.01% 2695
2022
Q4
Sell
-12,256
Closed -$98K 3075
2022
Q3
$98K Sell
12,256
-92,452
-88% -$980K ﹤0.01% 2747
2022
Q2
$1.21M Buy
+104,708
New +$1.24M ﹤0.01% 1823
2022
Q1
Sell
-10,561
Closed -$69K 3313
2021
Q4
$69K Buy
+10,561
New +$72.5K ﹤0.01% 3182
2021
Q1
Sell
-18,507
Closed -$62K 2836
2020
Q4
$62K Buy
+18,507
New +$69.5K ﹤0.01% 2978
2019
Q4
Sell
-11,834
Closed -$185K 3077
2019
Q3
$185K Sell
11,834
-3,003
-20% -$49.2K ﹤0.01% 2886
2019
Q2
$217K Buy
+14,837
New +$294K ﹤0.01% 2505

Other funds holding EOLS

HSBC Holdings's EOLS Position: Q1 2026 in Review

HSBC Holdings opened a new position in Evolus (EOLS) in Q1 2026: 34,288 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #2695 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in EOLS as recently as Q3 2022.

HSBC Holdings first reported a position in EOLS in Q2 2019 and has held it in 7 quarters since. The position peaked at $1.21M in Q2 2022. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • HSBC Holdings held 34,288 shares of Evolus worth $142K as of Q1 2026.
  • Evolus was a new HSBC Holdings position in Q1 2026.
  • Evolus made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2695 holding.
  • HSBC Holdings first reported a position in Evolus in Q2 2019 and has held it in 7 quarters since.
  • HSBC Holdings's Evolus position peaked at $1.21M in Q2 2022.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.